Daiwa Securities Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-128
| Closed | -$3K | – | 1369 |
|
|
2025
Q4 | $3K | Sell |
128
-41
| -24% | -$975 | ﹤0.01% | 1283 |
|
|
2025
Q3 | $4K | Hold |
169
| – | – | ﹤0.01% | 1225 |
|
|
2025
Q2 | $4K | Hold |
169
| – | – | ﹤0.01% | 1177 |
|
|
2025
Q1 | $4K | Hold |
169
| – | – | ﹤0.01% | 1153 |
|
|
2024
Q4 | $3K | Hold |
169
| – | – | ﹤0.01% | 1200 |
|
|
2024
Q3 | $3K | Hold |
169
| – | – | ﹤0.01% | 1202 |
|
|
2024
Q2 | $5K | Hold |
169
| – | – | ﹤0.01% | 1201 |
|
|
2024
Q1 | $5K | Hold |
169
| – | – | ﹤0.01% | 1212 |
|
|
2023
Q4 | $6K | Hold |
169
| – | – | ﹤0.01% | 1197 |
|
|
2023
Q3 | $5K | Hold |
169
| – | – | ﹤0.01% | 1161 |
|
|
2023
Q2 | $7K | Hold |
169
| – | – | ﹤0.01% | 1156 |
|
|
2023
Q1 | $7K | Hold |
169
| – | – | ﹤0.01% | 1135 |
|
|
2022
Q4 | $7K | Hold |
169
| – | – | ﹤0.01% | 1133 |
|
|
2022
Q3 | $9K | Hold |
169
| – | – | ﹤0.01% | 1131 |
|
|
2022
Q2 | $10K | Buy |
169
+39
| +30% | +$2.56K | ﹤0.01% | 1143 |
|
|
2022
Q1 | $10K | Hold |
130
| – | – | ﹤0.01% | 1139 |
|
|
2021
Q4 | $8K | Sell |
130
-22
| -14% | -$1.21K | ﹤0.01% | 1163 |
|
|
2021
Q3 | $9K | Buy |
152
+70
| +85% | +$4.03K | ﹤0.01% | 1150 |
|
|
2021
Q2 | $5K | Hold |
82
| – | – | ﹤0.01% | 1075 |
|
|
2021
Q1 | $6K | Hold |
82
| – | – | ﹤0.01% | 1070 |
|
|
2020
Q4 | $5K | Sell |
82
-154
| -65% | -$9.02K | ﹤0.01% | 1056 |
|
|
2020
Q3 | $14K | Hold |
236
| – | – | ﹤0.01% | 1023 |
|
|
2020
Q2 | $8K | Hold |
236
| – | – | ﹤0.01% | 1082 |
|
|
2020
Q1 | $8K | Hold |
236
| – | – | ﹤0.01% | 1074 |
|
|
2019
Q4 | $11K | Sell |
236
-26
| -10% | -$1.1K | ﹤0.01% | 1054 |
|
|
2019
Q3 | $10K | Hold |
262
| – | – | ﹤0.01% | 1034 |
|
|
2019
Q2 | $11K | Hold |
262
| – | – | ﹤0.01% | 1051 |
|
|
2019
Q1 | $10K | Buy |
262
+38
| +17% | +$1.48K | ﹤0.01% | 1035 |
|
|
2018
Q4 | $10K | Hold |
224
| – | – | ﹤0.01% | 998 |
|
|
2018
Q3 | $11K | Hold |
224
| – | – | ﹤0.01% | 1032 |
|
|
2018
Q2 | $7K | Hold |
224
| – | – | ﹤0.01% | 1073 |
|
|
2018
Q1 | $7K | Buy |
+224
| New | +$7.98K | ﹤0.01% | 1057 |
|
Other funds holding PCRX
DPCM
VPM
VCM
Daiwa Securities Group's PCRX Position: Q1 2026 in Review
Daiwa Securities Group sold out of Pacira BioSciences (PCRX) in Q1 2026, closing a stake of 128 shares — an estimated $3K sold.
Daiwa Securities Group first reported a position in PCRX in Q1 2018 and held it in 32 quarters. The position peaked at $14K in Q3 2020. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.
- Daiwa Securities Group reported no remaining Pacira BioSciences position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 128 Pacira BioSciences shares in Q1 2026, an estimated $3K.
- Daiwa Securities Group first reported a position in Pacira BioSciences in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's Pacira BioSciences position peaked at $14K in Q3 2020.
- 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.